News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Karen Knudsen: Thomas Lynch on how to address headwinds to cancer science and cancer care delivery
Thomas Lynch/fredhutch.org
Mar 30, 2025, 03:54

Karen Knudsen: Thomas Lynch on how to address headwinds to cancer science and cancer care delivery

Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS), shared a post on LinkedIn:

“Brilliant start to CCX (Cancer Care at the Crossroads), with an expert panel led by the incomparable Thomas Lynch on how to address headwinds to cancer science and cancer care delivery.

A more important discussion than ever!”

Karen Knudsen: Thomas Lynch on how to address headwinds to cancer science and cancer care delivery

 

More posts featuring Karen Knudsen.

ACS American Cancer Society cancer Cancer Care at the Crossroads cancer care delivery cancer science CCX fight against cancer Global fight against cancer Karen Knudsen OncoDaily Oncology Thomas Lynch
Special Coverage
Blog
Apr 1, 2025, 07:58
Significant HHS Workforce Reduction and Restructuring Threaten the Nation’s Fight Against Cancer - ACS CAN
Blog
Apr 1, 2025, 07:51
Michele Carbone: Is there a future for cancer research in the USA?
Blog
Apr 1, 2025, 07:49
LUNGevity Foundation - Registration is open for the HOPE Summit25
Insight
Apr 1, 2025, 07:47
AACR GENIE 17.0 release provides insights into its genomic landscape
Blog
Apr 1, 2025, 07:32
Shravan Nadkarni: Registration is open for the Laparoscopic Colorectal Surgery Live Workshop
Science
Apr 1, 2025, 07:29
Talha Badar: Predictors of CNS relapse in APL
Blog
Apr 1, 2025, 07:24
Jenny Seligmann: World-class discovery science and clinicians collaborating on colorectal trial cohorts
Opinion
Apr 1, 2025, 07:19
Yüksel Ürün: Low-dose CT for lung cancer screening in a high-risk population
Blog
Apr 1, 2025, 07:09
Virginia Galvín: Should critical medications be integrated into defense budgets?
Blog
Apr 1, 2025, 06:51
Kendra Paabo: The 3 worst words you can say to someone with cancer
Blog
Apr 1, 2025, 06:49
Ali Atoui: Honored to Receive the 2025 CHAMP Award from the American Society of Hematology
Drugs
Apr 1, 2025, 06:49
Tislelizumab (Tevimbra): What Patients need to know?